Once for Life

Once for Life

Creating transformational gene therapies and peptide infusions that treat the most prevalent diseases to restore health and renew life.

Renova Therapeutics envisions a future in which we’re able to permanently treat chronic diseases with gene and peptide therapies. Right now, we’re developing definitive, one-time treatments to restore health to people suffering from some of the most common and devastating chronic conditions in the world: congestive heart failure and type 2 diabetes.

Tell Us Who You Are, And We'll Guide You Through our Site


Latest News:  Dec. 1, 2016 | PRESS RELEASE: Genetic Rx panel on gene therapy to feature Renova Therapeutics CEO and Co-founder

  Nov. 11, 2016 | CARDIOLOGY TODAY: Phase 3 trial of gene transfer therapy for patients with HF to launch

  Nov. 1, 2016 | PRESS RELEASE: Renova Therapeutics announces successful End-of-Phase 2 meeting with FDA for RT-100 AC6 gene transfer therapy

View All News
Subscribe to receive company press releases and announcements